InMode (INMD) Net Shares Issued and Repurchased (2020 - 2026)

InMode (INMD) posted quarterly Net Shares Issued and Repurchased of -$31.2 million for Q1 2026, up 68.75% year-on-year from -$18.5 million in Q1 2025, and down 13.67% on a QoQ basis from -$27.5 million in Q2 2025.

InMode (INMD) Net Shares Issued and Repurchased (2020 - 2026) Analysis & Trends

InMode (INMD) has reported Net Shares Issued and Repurchased for 6 consecutive years, with -$31.2 million the latest figure, recorded in Q1 2026.

  • Quarterly Net Shares Issued and Repurchased rose 68.75% year-over-year to -$31.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$58.7 million (up 84.76% YoY) and the FY2025 annual result came in at -$127.4 million, up 55.34% from the prior year.
  • Net Shares Issued and Repurchased declined to -$31.2 million in Q1 2026 per INMD's latest filing, from -$27.5 million in the prior quarter.
  • Over the last five years, Net Shares Issued and Repurchased for INMD reached as high as -$27.5 million in Q2 2025 and fell as low as -$119.8 million in Q4 2024.
  • A 4-year average of -$69.5 million and a median of -$76.6 million in 2024 frame the typical range for Net Shares Issued and Repurchased.
  • Annual changes were most pronounced in 2022 — Net Shares Issued and Repurchased tumbled 4834.84% — and 2025, when it jumped 69.11%.
  • Year by year, Net Shares Issued and Repurchased stood at -$42.6 million in 2022, then tumbled by 181.09% to -$119.8 million in 2024, then soared by 77.07% to -$27.5 million in 2025, then slipped by 13.67% to -$31.2 million in 2026.
  • According to Business Quant data, Net Shares Issued and Repurchased over the past three periods registered -$31.2 million, -$27.5 million, and -$100.0 million for Q1 2026, Q2 2025, and Q1 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Shares Issued (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn -
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn -
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn -
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn -
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn -
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn -
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 InMode 956,721.10 -479.17 Mn 61.55 Mn -31.24 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -31.24 Mn
Mar 31, 2026 -31.24 Mn
Jun 30, 2025 -27.48 Mn
Jun 30, 2025 -27.48 Mn
Mar 31, 2025 -99.96 Mn
Mar 31, 2025 -99.96 Mn
Dec 31, 2024 -119.85 Mn
Dec 31, 2024 -119.85 Mn
Sep 30, 2024 -76.56 Mn
Sep 30, 2024 -76.56 Mn
Jun 30, 2024 -88.98 Mn
Jun 30, 2024 -88.98 Mn
Mar 31, 2022 -42.64 Mn
Mar 31, 2022 -42.64 Mn
Dec 31, 2021 -23.44 Mn
Dec 31, 2021 -23.44 Mn
Jun 30, 2021 -11.06 Mn
Jun 30, 2021 -11.06 Mn
Mar 31, 2021 -864,000.00
Mar 31, 2021 -864,000.00